Koers Tetralogic Pharmaceuticals Corp Nasdaq
Aandelen
US88165U1097
Biotechnologie & Medisch Onderzoek
Omzet 2014 | - | Omzet 2015 | - | Marktkapitalisatie | 42,07 mln. 38,71 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -36 mln. -33,12 mln. | Nettowinst (verlies) 2015 | -49 mln. -45,08 mln. | EV/omzet 2014 | - |
Nettoliquiditeiten 2014 | 22,32 mln. 20,53 mln. | Nettoschuld 2015 | 7,92 mln. 7,29 mln. | EV/omzet 2015 | - |
K/w-verhouding 2014 |
-2,96
x | K/w-verhouding 2015 |
-0,82
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
President | - | - | |
Treasurer | 66 | 01-02-14 | |
Dick L. Sherman
SEC | Corporate Secretary | 76 | 01-11-12 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,58% | 115 mld. | |
+12,41% | 107 mld. | |
-3,44% | 21,6 mld. | |
-12,38% | 22,31 mld. | |
-6,91% | 19,19 mld. | |
-3,35% | 18,23 mld. | |
-38,57% | 17,62 mld. | |
+7,51% | 14,26 mld. | |
+35,67% | 12,37 mld. |